多西紫杉醇主要作用于肿瘤细胞的M期,属细胞周期特异性药物。抗肿瘤效果与紫杉醇相当,或对部分肿瘤的疗效稍高于紫杉醇。临床上主要用于卵巢癌、转移性乳腺癌和非小细胞肺癌等,疗效显著。多西紫杉醇的主要不良反应包括骨髓抑制、液体潴留、血管性水肿、过敏反应、消化道反应等。本文就多西紫杉醇不良反应类型及临床上采取的预防和常规处理方法进行探讨。 Docetaxel mainly acts on the M phase of tumor cells, which is a cell cycle-specific drug. The anti-tumor effect is equivalent to paclitaxel, or the efficacy of some tumors is slightly higher than that of paclitaxel. Clinical mainly for ovarian cancer, metastatic breast cancer and non-small cell lung cancer, a significant effect. The main adverse reactions of docetaxel include myelosuppression, fluid retention, angioedema, allergic reactions, gastrointestinal reactions. In this paper, the type of docetaxel adverse reactions and clinical prevention and routine treatment methods are discussed.